Advertisement

Ads Placeholder
Loading...

National Research Corporation

NRC•NASDAQ
Healthcare
Medical - Healthcare Information Services
$17.16
$-0.18(-1.04%)
U.S. Market opens in 20h 4m

National Research Corporation (NRC) Stock Overview

Explore National Research Corporation’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap390.3M
P/E Ratio32.23
EPS (TTM)$0.50
ROE0.59%
Fundamental Analysis

AI Price Forecasts

1 Month$13.95
3 Months$13.98
1 Year Target$13.27

NRC Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of National Research Corporation (NRC) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 56.64, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $13.27.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 32.23 and a market capitalization of 390.3M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-1.04%
5-Day Change
-1.10%
1-Month Change
28.16%
3-Month Change
-4.83%
6-Month Change
40.54%
Year-to-Date (YTD) Change
-4.83%
1-Year Change
43.96%
3-Year Change
-61.59%
5-Year Change
-64.02%
All-Time (Max) Change
-14.20%

Contact Information

https://nrchealth.com
402 475 2525
1245 Q Street, Lincoln, NE, 68508

Company Facts

3,680 Employees
IPO DateMay 23, 2013
CountryUS
Actively Trading

Frequently Asked Questions